Merck KGaA

In News

Merck KGaA targets 2 billion euros in sales from new drugs by 2022 - FirstWord Pharma

FirstWord Pharma - Jul 05, 2025

Drugmaker Wants £46M For MSD's Use Of 'Merck' In UK - Law360

Law360 - Jul 08, 2025

Merck Completes Acquisition of SpringWorks Therapeutics to Accelerate Sustainable Growth of its Healthcare Business - Merck Group

Merck Group - Jul 01, 2025

Merck KGaA sheds light on failed portion of phase 2 lupus trial, keeps sights on regulators - Fierce Biotech

Fierce Biotech - Jun 12, 2025

Merck KGaA to buy biotech SpringWorks for $3.9B - BioPharma Dive

BioPharma Dive - Apr 28, 2025

ASCO25: Merck KGaA’s ADC shows safety and tolerability in colorectal cancer trial - Clinical Trials Arena

Clinical Trials Arena - May 30, 2025

Merck KGaA cites Trump tariffs, funding cuts as it scales back 2025 contracting forecast - Fierce Pharma

Fierce Pharma - May 15, 2025

Research Antibodies Market Accelerates as Precision Medicine - openPR.com

openPR.com - Jul 09, 2025

Merck KGaA nears $3.5bn deal for SpringWorks - Pharmaceutical Technology

Pharmaceutical Technology - Apr 25, 2025

Merck KGaA, Darmstadt, Germany Acquires SpringWorks Therapeutics for $3.4M - Contract Pharma

Contract Pharma - Jul 01, 2025

Biomanufacturing giant Merck KGaA slimming down French in Martillac plant due to CDMO market tensions - BioProcess International

BioProcess International - Apr 08, 2025

Merck KGaA to Acquire SpringWorks for $3.9B, Expanding Rare Cancer Footprint - Genetic Engineering and Biotechnology News

Genetic Engineering and Biotechnology News - Apr 29, 2025

Stay Informed

Join our mailing list for the latest report releases and upcoming event notifications.

Headquartered in Boston, Mass., for over 50 years, BCC Research takes pride in being your trusted custom research and data analysts. Our mission is to provide businesses with reputable data and market research reports, so that they gain new perspectives into their field and better understand their target audience. We enable companies to access reliable information, accurate forecasts, and actionable insights, so that they may become leaders in their industry.